Prognostic prediction of glioblastoma by quantitative assessment of the methylation status of the entire MGMT promoter region

BACKGROUND: O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation is reported to be a prognostic and predictive factor of alkylating chemotherapy for glioblastoma patients. Methylation specific PCR (MSP) has been most commonly used when the methylation status of MGMT is assessed. Howeve...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kanemoto, Manabu, Shirahata, Mitsuaki, Nakauma, Akiyo, Nakanishi, Katsumi, Taniguchi, Kazuya, Kukita, Yoji, Arakawa, Yoshiki, Miyamoto, Susumu, Kato, Kikuya
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4161852/
https://ncbi.nlm.nih.gov/pubmed/25175833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-641
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky